Skip to Content
Merck

870202O

Avanti

18:1 PDP PE

Avanti Research™ - A Croda Brand

Synonym(s):

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[3-(2-pyridyldithio)propionate] (sodium salt)

Sign Into View Organizational & Contract Pricing

Select a Size

About This Item

Empirical Formula (Hill Notation):
C49H84N2O9PNaS2
CAS Number:
474944-13-3
Molecular Weight:
963.29
MDL number:
MFCD22495340
UNSPSC Code:
12352211
NACRES:
NA.25

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

18:1 PDP PE, Avanti Research™ - A Croda Brand 870202O

Assay

>99% (TLC)

form

liquid

packaging

pkg of 1 × 25 mg (870202O-25mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 870202O

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@@](COP([O-])(OCCNC(CCSSC1=CC=CC=N1)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]

InChI

1S/C49H85N2O9PS2.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-36-48(53)57-43-45(60-49(54)37-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)44-59-61(55,56)58-41-40-50-46(52)38-42-62-63-47-35-33-34-39-51-47;/h17-20,33-35,39,45H,3-16,21-32,36-38,40-44H2,1-2H3,(H,50,52)(H,55,56);/q;+1/p-1/b19-17-,20-18-;/t45-;/m1./s1

InChI key

LFMWVVNPVNIPJG-JQRYTBKHSA-M

General description

18:1 PDP PE, also referred as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[3-(2-pyridyldithio)propionate], is a head group modified functionalized lipid. Functionalized lipids mainly act as reporter molecules.

Application

18:1 PDP PE may be used in the preparation of hydrophobized disulfide-linked oligodeoxyribonucleotide (ODN). It may also be used in the preparation of liposomes.

Packaging

5 mL Clear Glass Sealed Ampule (870202O-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Pathways for modulating exosome lipids identified by high-density lipoprotein-like nanoparticle binding to scavenger receptor type B-1
Angeloni NL, et al.
Scientific reports, 6(1) (2016)
Disulfide-linked liposomes: effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139
Weecharangsan W, et al.
Anticancer Research, 30(1), 31-37 (2010)
Hitchhiking nanoparticles: Reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytes
Wayteck L, et al.
Biomaterials, 77, 243-254 (2016)
Laura Wayteck et al.
Biomaterials, 77, 243-254 (2015-11-26)
Following intravenous injection of anti-cancer nanomedicines, many barriers need to be overcome en route to the tumor. Cell-mediated delivery of nanoparticles (NPs) is promising in terms of overcoming several of these barriers based on the tumoritropic migratory properties of particular
Lindsay Scheetz et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 26(16), 4369-4380 (2020-05-23)
Gliomas are brain tumors with dismal prognoses. The standard-of-care treatments for gliomas include surgical resection, radiation, and temozolomide administration; however, they have been ineffective in providing significant increases in median survival. Antigen-specific cancer vaccines and immune checkpoint blockade may provide
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service